Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Lægehuset Helgolandsgade alment praktiserende læge ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 N/A 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   0.0% 4.6% 2.9% 2.2% 2.2% 1.2% 16.1% 15.8%   Credit score (0-100)   0 47 58 65 65 81 11 12   Credit rating   N/A BBB BBB BBB BBB A BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.1 0.1 49.4 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 N/A 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   0.0 2,647 2,589 2,418 2,504 2,470 0.0 0.0   EBITDA   0.0 575 601 436 672 615 0.0 0.0   EBIT   0.0 535 561 396 672 594 0.0 0.0   Pre-tax profit (PTP)   0.0 504.6 539.5 387.7 660.0 583.6 0.0 0.0   Net earnings   0.0 391.8 419.3 303.0 512.7 451.5 0.0 0.0   Pre-tax profit without non-rec. items   0.0 505 539 388 660 584 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 N/A 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Tangible assets total   0.0 80.0 40.0 0.0 0.0 541 0.0 0.0   Shareholders equity total   0.0 442 619 703 913 852 350 350   Interest-bearing liabilities   0.0 31.1 0.0 0.0 0.0 431 0.0 0.0   Balance sheet total (assets)   0.0 836 1,301 1,174 1,208 1,724 350 350   Net Debt   0.0 -355 -879 -700 -825 -447 -350 -350     See the entire balance sheet 1000.0 Volume  2018 N/A 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   0.0 2,647 2,589 2,418 2,504 2,470 0.0 0.0   Gross profit growth   0.0% 0.0% -2.2% -6.6% 3.5% -1.4% -100.0% 0.0%   Employees   0 3 3 3 3 3 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 836 1,301 1,174 1,208 1,724 350 350   Balance sheet change%   0.0% 0.0% 55.5% -9.8% 2.9% 42.7% -79.7% 0.0%   Added value   0.0 574.8 600.6 436.2 711.8 614.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 40 -80 -80 0 520 -541 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   0.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   1000.0 Profitability  2018 N/A 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 20.2% 21.7% 16.4% 26.8% 24.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.0% 63.9% 52.5% 32.0% 56.4% 40.5% 0.0% 0.0%   ROI %   0.0% 112.0% 102.2% 59.9% 83.2% 53.5% 0.0% 0.0%   ROE %   0.0% 88.7% 79.0% 45.8% 63.5% 51.2% 0.0% 0.0%   1000.0 Solidity  2018 N/A 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Equity ratio %   0.0% 52.8% 47.6% 59.9% 75.5% 49.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% -61.7% -146.4% -160.6% -122.9% -72.8% 0.0% 0.0%   Gearing %   0.0% 7.0% 0.0% 0.0% 0.0% 50.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 194.0% 135.9% 0.0% 0.0% 4.9% 0.0% 0.0%   1000.0 Liquidity  2018 N/A 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Quick Ratio   0.0 1.8 1.8 2.4 3.9 2.4 0.0 0.0   Current Ratio   0.0 1.8 1.8 2.4 3.9 2.4 0.0 0.0   Cash and cash equivalent   0.0 385.8 879.4 700.4 825.5 878.3 0.0 0.0   1000.0 Capital use efficiency  2018 N/A 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 318.1 531.2 654.8 864.5 665.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 N/A 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 192 200 145 237 205 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 192 200 145 224 205 0 0   EBIT / employee   0 178 187 132 224 198 0 0   Net earnings / employee   0 131 140 101 171 151 0 0